Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > ARC Dialysis

<< Previous

Bullboard Posts

Next >>

Comment by Rickkieon Jun 16, 2022 9:33am

183 Views

Post# 34760860

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ARC Dialysis

Listen JC, I’m just as excited as any other long-time shareholder to get a great news release, but can we just stick to the facts?

You are willing to share your info over and over, but when challenged to share the source, you resort to sarcasm and insults. Interesting!

Also, your “assumed” 6 other states plus Florida, does not account for 34% of the US population – far from it - according to the 2020 census.

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly